Effects of Vonoprazan on the Antiplatelet Function of Prasugrel Assessed by the VerifyNow P2Y(12) Assay in Patients With Coronary Artery Disease

Background: Vonoprazan is a potassium-competitive acid blocker increasingly used in Japan to prevent upper gastrointestinal bleeding in patients undergoing dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Cytochrome P450 (CYP) 3A4 is involved in the primary metabolism...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Circ Rep
Main Authors: Koga, Seiji, Ikeda, Satoshi, Akashi, Ryohei, Yonekura, Tsuyoshi, Kawano, Hiroaki, Maemura, Koji
Format: Artigo
Sprog:Inglês
Udgivet: The Japanese Circulation Society 2020
Fag:
Original article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7939790/
https://ncbi.nlm.nih.gov/pubmed/33693287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-20-0124
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker